XBiotech
XBIT
XBIT
48 hedge funds and large institutions have $59.3M invested in XBiotech in 2017 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 16 increasing their positions, 16 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
2% less funds holding
Funds holding: 49 → 48 (-1)
12% less call options, than puts
Call options by funds: $2.9M | Put options by funds: $3.29M
Holders
48
Holding in Top 10
–
Calls
$2.9M
Puts
$3.29M
Top Buyers
| 1 | +$21.3M | |
| 2 | +$1.07M | |
| 3 | +$862K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$559K |
| 5 |
Goldman Sachs
New York
|
+$403K |
Top Sellers
| 1 | -$621K | |
| 2 | -$572K | |
| 3 | -$504K | |
| 4 |
SO
STRS Ohio
Columbus,
Ohio
|
-$333K |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$234K |